Literature DB >> 16546549

Progress of DOTS in global tuberculosis control.

S K Sharma1, J J Liu.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16546549     DOI： 10.1016/S0140-6736(06)68391-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  TMC207: the first compound of a new class of potent anti-tuberculosis drugs.

Authors:  Alberto Matteelli; Anna Cc Carvalho; Kelly E Dooley; Afranio Kritski
Journal:  Future Microbiol       Date:  2010-06       Impact factor: 3.165

2.  Multidrug and extensively drug-resistant tuberculosis from a general practice perspective.

Authors:  B M Yashodhara; Choo Beng Huat; Lakshmi Nagappa Naik; Shashikiran Umakanth; Manjunatha Hande; Joseph M Pappachan
Journal:  Infect Drug Resist       Date:  2010-10-22       Impact factor: 4.003

3.  Evaluation of CD4+ CD25+ FoxP3+ Regulatory T cells and FoxP3 and CTLA-4 gene Expression in Patients wwith Newly Diagnosed Tuberculosis in Northeast of Iran.

Authors:  Roghayeh Ghazalsofala; Seyed Abdolrahim Rezaee; Houshang Rafatpanah; Rosita Vakili; Kiarash Ghazvini; Fatemeh Heidarnejad; Somaye Sobhani; Narges Valizadeh; Marayam Azami; Marzieh Rahimzadegan; Amir Asnaashari
Journal:  Jundishapur J Microbiol       Date:  2015-04-18       Impact factor: 0.747

4.  Experiences in anti-tuberculosis treatment in patients with multiple previous treatments and its impact on drug resistant tuberculosis epidemics.

Authors:  Biao Xu; Qi Zhao; Yi Hu; Ying Shi; Weibing Wang; Vinod K Diwan
Journal:  Glob Health Action       Date:  2014-08-18       Impact factor: 2.640

5.  Medical management of genitourinary tuberculosis.

Authors:  Tamilarasu Kadhiravan; Surendra K Sharma
Journal:  Indian J Urol       Date:  2008-07

6.  What happens to people diagnosed with tuberculosis? A population-based cohort.

Authors:  N Anyama; S Bracebridge; C Black; A Niggebrugge; S J Griffin
Journal:  Epidemiol Infect       Date:  2007-02-09       Impact factor: 2.451
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.